5325042025-10-012025-12-315325042025-04-012025-12-315325042025-10-012025-12-31in-capmkt:OtherExpenses1Member5325042025-04-012025-12-31in-capmkt:OtherExpenses1Member5325042025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15325042025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15325042025-10-012025-12-31ItemsThatWillBeReclassifiedToProfitAndLoss15325042025-04-012025-12-31ItemsThatWillBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares532504NAVINFLUORNOTLISTEDINE048G01026Navin Fluorine International LimitedMain BoardEquity2025-04-012026-03-312026-02-092025-12-23INRCroresQuarterlyThird quarterSingle segmentChemicals2026-02-0913:45:002026-02-0916:00:00Not applicable2025-10-012025-12-31UnauditedConsolidated8923700000155800000907950000035937000001220000071300000756500000282600000361600000141430000064922000002587300000-204700000238260000034880000017980000052860000001854000000000018540000001000000018640000001854000000018640000000102500000236.1836.130036.1836.131. The results of the quarter and nine months ended 31st December, 2025 were reviewed by the Audit Committee and approved by the Board of Directors of the Company at its meeting held on 9th February, 2026. They have been subjected to limited review by the statutory auditors. <BR> <BR> 2. During the quarter ended 31st December, 2025 the Company paid an interim dividend of Rs 6.50 per share (325%) on 5,12,39,124 equity shares of nominal value of Rs. 2/- each aggregating to Rs 33.31 crores, for the financial year 2025-26. <BR> <BR> 3. During the quarter ended 30th September, 2025, the Fund raising committee at its meeting held on 11th July, 2025 has approved the allotment of 16,02,564 Equity Shares of Rs 2/- each through Qualified Institutional Placement (QIP) under the provisions of Chapter VI of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and section 42 and 62 of the Companies Act, 2013, including the rules made thereunder as amended, to the eligible Qualified Institutional Buyers, at the issue price of Rs 4,680.00 per Equity Share (including a premium of 4,678.00 per Equity Share), aggregating to approximately Rs 750 crores. <BR> Expenses incurred in relation to QIP have been adjusted from Securities Premium Account. The funds raised by the Company pursuant to QIP have been fully utilized in accordance with the 'Use of Proceeds' mentioned in the placement document of QIP. <BR> <BR> 4. Pursuant to the notification issued by the Ministry of Labour and Employment, multiple existing labour legislations have been consolidated into a unified framework comprising four Labour Codes, collectively referred to as the ' New Labour Codes ' which became effective from 21st November, 2025. The Group has reassessed its employee benefit obligations in accordance with the revised definition of wages. Accordingly, an estimated incremental liability on employee benefit amounting to Rs 20.47 crores has been recognized as an " Exceptional item " during the quarter and nine months ended 31st December, 2025. The Group is monitoring updates on the rules and clarifications by State and / or Central Government authorities in relation to the New Labour Codes and impact of those will be evaluated and accounted for in the period in which they are notified. <BR> <BR> 5. The Group operates only in one Business Segment i.e. `Chemical Business` which constitutes single reportable segment in accordance with the requirements of Ind AS 108, ‘Operating Segments’. <BR> <BR> 6. The consolidated results include the financial results of three foreign subsidiaries – Manchester Organics Limited, NFIL (UK) Limited and Navin Fluorine (Shanghai) Co. Limited, a step-down foreign subsidiary – NFIL USA Inc., a 100% subsidiary of NFIL (UK) Limited, two Indian subsidiaries – Sulakshana Securities Limited and Navin Fluorine Advanced Sciences Limited, and a joint venture company – Swarnim Gujarat Fluorspar Private Limited. <BR> 2025-04-012025-12-31UnauditedConsolidated2376190000047700000024238900000963190000077600000173800000226260000088910000010798000004010700000181255000006113400000-20470000059087000001100400000298900000139930000004509400000000-1000004509300000830000045176000004509300000045176000000102500000289.0688.930089.0688.93Other Expenses1414300000Other Expenses4010700000Remeasurement loss of the defined benefit obligation84000008400000Remeasurement loss of the defined benefit obligation-25200000-252000002300000-6000000Exchange difference on translation of foreign operations39000003900000Exchange difference on translation of foreign operations275000002750000000100000008300000